Countdown to Cashflow Positive, page-2

I suspect that the trend in ACR's share price will be set with the announcement of how well or bad Dash Pharma's sales are going with our testosterone generic. That should help in accessing the chances of being cash flow positive by the end of this year. Also I've noticed that its taking a while to announce a new Pharma Coy to manage the Elma Cream generic, now that Harris Pharma is kaput. Plus there is still no news on when Jublia generic can be launched. A big ask to be cashflow positive by the end of the year as of now...5th Jan 2022. Some really good news about the cash coming in is required. It's coming up to 7 years soon when this strategy started. Jet